Seeing how the Short Physical Performance Battery works for people with Parkinson's in Galicia
Official title: Observational Study for the Functional Characterization of the Population Diagnosed With Parkinson's Disease in Galicia, and Validation of the Short Physical Performance Battery in Individuals Diagnosed With Parkinson's Disease
Run by University of Vigo · NCT07780461 · Data updated 2026-11-12
This study tests whether the Short Physical Performance Battery (SPPB) is reliable and valid for adults with Parkinson's disease living in Galicia, Spain.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | University of Vigo Academic / other |
| Locations | 2 sites (Pontevedra, Pontevedra and 1 other locations) |
| Status | Recruiting |
| Started | August 1, 2026 |
| Main results expected | November 25, 2026 |
| Study ends | December 25, 2026 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT07780461 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults diagnosed with Parkinson's disease living in Galicia who can complete the assessment procedures and provide informed consent.
✕Probably not a fit
Patients unable to complete study assessments or who do not align with the PD population in Galicia may not benefit from this validation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter observational study characterizes the functional, cognitive, and sociodemographic profiles of people with Parkinson's disease in Galicia. It evaluates the psychometric properties of the Short Physical Performance Battery (SPPB) to determine its reliability, internal consistency, and construct validity in this population. Participants undergo a comprehensive assessment of mobility, balance, strength, cognitive status, physical activity, and disease severity. The goal is to determine if the SPPB is a practical and accurate tool for clinical and research use in PD patients in Galicia. Findings could inform how physical function is measured in this group and support standardized assessments in future studies and care plans.
Why it matters
Potential benefit: If successful, the SPPB could provide clinicians with a reliable, quick measure of lower-body function to guide treatment and monitoring in Parkinson's patients.
How similar studies have gone: Previous research supports the SPPB in older adults and other conditions, but validation in Parkinson's disease remains limited and context-specific, making this study an important step.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease confirmed by a neurologist. * Provision of written informed consent by the participant or, when applicable, by a legally authorized representative. Exclusion Criteria: * Inability to complete the study assessment procedures.
Where it's running
-
Asociación de Parkinson de la Provincia de Pontevedra
Pontevedra, Pontevedra, Spain Recruiting -
Facultad de Fisioterapia
Pontevedra, Pontevedra, Spain Recruiting
Study contacts
- Principal investigator: Irimia Mollinedo-Cardalda, PT, PhD — Universidade de Vigo
- Study coordinator: Irimia Mollinedo-Cardalda, PT, PhD
- Email: imollinedo@uvigo.es
- Phone: +34986801771
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
UX-DA003 injections for Parkinson's disease
This early-phase trial tests whether injecting UX-DA003 is safe and may help motor symptoms in people with Parkinson's whose response to standard treatments has declined.
-
Strength and dual-task training to help people with Parkinson’s improve strength and function
This trial tests three levels of physiotherapy, including progressive resistance training with and without cognitive dual-task and instability components, to see if they improve muscle strength, body composition, and physical function in adults with Parkinson’s or related syndromes.
-
Spinal Mobility, Rigidity, and Kinesiophobia in Parkinson's Disease with and without TMD
This study tests whether people with Parkinson's disease who have Temporomandibular Disorders differ in spinal mobility, axial rigidity, and kinesiophobia from those without TMD.
-
A 12-Week Trial of Flexilev with the OraFID Device and App for Parkinson's
This study tests whether taking small, precise doses of Flexilev with the OraFID dosing device and Levilog app is acceptable and helps people with Parkinson's manage their medicine.
-
Integrated Motor-Cognitive Training in Parkinson's Disease
This study tests a combined motor and cognitive rehabilitation program to see if people with Parkinson’s disease can stick with it and show early signs of benefit.
-
VIM0423 for Parkinson's Tremor in Adults Not Fully Controlled by Dopaminergic Therapy
A Vima Therapeutics study tests whether the oral drug VIM0423 can reduce tremor in adults with Parkinson’s disease who still have tremor despite dopaminergic treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.